JDS Pharmaceuticals Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

JDS Pharmaceuticals General Information

Description

Provider of services in in the acquisition, development, and marketing of in-line and late-stage developmental pharmaceutical products. The company offers Pexeva for major depressive disorders, panic disorders, and obsessive compulsive disorders; and Lithobid for bipolar disorders. It identifies, develops, and delivers safe medicines.

Contact Information

Website
www.jdspharma.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 405 Lexington Avenue
  • The Chrysler Building, 59th Floor
  • New York, NY 10174
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

JDS Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore JDS Pharmaceuticals‘s full profile, request access.

Request a free trial

JDS Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Phillip Satow Founder & Chief Executive Officer
Daniel Kreisler Vice President
You’re viewing 2 of 4 executive team members. Get the full list »